[afro-nets] HIV Prevention Update

["Anna Lisi" <anna_lisi@jsi.com>]

Below are the headlines from the most recent HIV Prevention Update from AIDSTAR-One. The full summaries of these recent articles can be accessed at http://j.mp/zzEk2x. 

VOICE Trial Discontinues Research on Tenofovir Gel 
From: Microbicides Trial Network
The Vaginal and Oral Interventions to Control the Epidemic (VOICE) trial has discontinued the 1 percent tenofovir gel research from the study due to results demonstrating its lack of effectiveness in preventing HIV among women enrolled in the trial.  

Combination Prevention Can Result in Effective Prevention 
From: AIDS
Because no single prevention package will address all epidemics around the world, combination prevention approaches are the most appropriate response to the "know your epidemic" and "know your response" imperative. To achieve intended prevention results, combination interventions must be tailored to the local context and adopt outcome and impact measurements to tease out the most efficient and cost-effective mix of behavioral, biomedical, and structural interventions.

Voluntary Medical Male Circumcision Gains Ground in Southern and East Africa 
From: PLoS Medicine and PLoS One
A series of articles in PLoS Medicine and a new framework from the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) discuss various factors in effective voluntary medical male circumcision (VMMC) programming, including cost implications, data for decision-making, policy frameworks, logistics, and human resources, and describe a plan to achieve 80 percent coverage in 13 high-priority countries in Southern and East Africa. 

HIV Partner Notification Is Effective and Feasible in Sub-Saharan Africa: Opportunities for HIV Treatment and Prevention
From: Journal of Acquired Immune Deficiency Syndromes

Safety and Efficacy of the PrePex Device for Rapid Scale-Up of Male Circumcision for HIV Prevention in Resource-Limited Settings
From: Journal of Acquired Immune Deficiency Syndromes

Antiretrovirals for Safer Conception for HIV-Negative Women and Their HIV-1-Infected Male Partners: How Safe and How Available?
From: Journal of Acquired Immune Deficiency Syndromes and AIDS

Optimal Uses of Antiretrovirals for Prevention in HIV-1 Serodiscordant Heterosexual Couples in South Africa: A Modelling Study
From: PLoS Medicine

Pre-exposure Prophylaxis for HIV Prevention: How to Predict Success
From: The Lancet

Breakthrough of the Year: HIV Treatment as Prevention AND ARVs as HIV Prevention: A Tough Road to Wide Impact 
From: Science

Moving Forward on Women's Gender-Related HIV Vulnerability: The Good News, the Bad News and What to Do About It
From: Global Public Health

Creating a Different International HIV Response for Young People
From: Global Public Health

Linkages Between HIV and Family Planning Services Under PEPFAR: Room for Improvement
From: Guttmacher Policy Review

What Works to Meet the Sexual and Reproductive Health Needs of Women Living with HIV/AIDS 
From: Journal of Acquired Immune Deficiency Syndromes

Global HIV/AIDS Response: Epidemic Update and Health Sector Progress Towards Universal Access, Progress Report 2011
From: Joint United Nations Programme on HIV/AIDS, WHO, and UNICEF

New Online Resources on MSM and Legal Issues 
From: Global Commission on HIV and the Law and the Global Forum on MSM & HIV (MSMGF)

PEPFAR Scientific Advisory Board Recommendations
From: Office of the U.S. Global AIDS Coordinator

Criminalize Hate Not HIV Campaign
From: International Planned Parenthood Federation


Anna Lisi
Production Manager
John Snow, Inc.
AIDSTAR-One
11th Floor
1616 N. Fort Myer Drive
Arlington, VA 22209
Tel. (703) 310-5044
Fax (703) 528-7480
mailto:alisi@jsi.com 
Learn about JSI at: www.jsi.com 
Visit AIDSTAR-One at: www.aidstar-one.com